Kapil Gururangan

Physician | Researcher | Educator

I am a neurology resident at the Icahn School of Medicine at Mount Sinai and a scientific advisor and consultant to Ceribell, Inc. I completed my undergraduate education at University of California, Berkeley and earned my MD from Stanford University School of Medicine.

1 Gustave L. Levy Place, New York, NY, 10029, USA 0000-0001-5247-8303 YVlV_WsAAAAJ&hl

All Pubs (2)Attributed Pubs (2)

Review 2: "The utility of established prognostic scores in COVID-19 hospital admissions: a multi-centre prospective evaluation of CURB-65, NEWS2, and qSOFA"

by Kapil Gururangan

Published: Aug 25, 2020

This robust analysis is novel and of high interest for the medical community. This study informs how new prognostic scores should be created to more accurately guide clinical decision-making in patients with COVID-19.

Reviews of "The utility of established prognostic scores in COVID-19 hospital admissions: a multicentre prospective evaluation of CURB-65, NEWS2, and qSOFA"

by Michael Meisner and Kapil Gururangan

Published: Aug 25, 2020

Reviewers: Michael Meisner (Städt. Krankenhaus Dresden-Neustadt) • Kapil Gururangan (Icahn School of Medicine at Mount Sinai)

Connections

Supplements (2):

Michael Meisner

•

Kapil Gururangan